Home » Topics » BioWorld Science

BioWorld Science
RSS

SB-238592: Antiinflammatory neuroprotectant in clinical phase

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

NMDA antagonists reported by Pfizer

May 17, 1996

Valproate effective in dementia patients

May 17, 1996

Increased platelet aggregation in AD patients

May 17, 1996

Sankyo claims allosteric muscarinic effectors for AD

May 17, 1996

GP-3269 on track for clinical testing

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Receptagen demerger on the table at AGM

May 17, 1996

Hafslund Nycomed demerger approved at AGM

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026